Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03762317 · ClinicalTrials.gov registry record · Phase 4
Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
A Phase 4 study, sponsored by Hennepin County Medical Center, Minneapolis.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03762317: Clinical Trial Phase 4 study, sponsored by Hennepin County Medical Center, Minneapolis.
NCT03762317 is a Phase 4 study that was terminated before completion, run by Hennepin County Medical Center, Minneapolis. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03762317, a Phase 4 study, was terminated before completion, sponsored by Hennepin County Medical Center, Minneapolis.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a prospective randomized double blinded study comparing the effect on duration of pharmacologic treatment and duration of hospital stay when using clonidine at 12 µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the management of term and near term infants with neonatal abstinence syndrome (NAS)
Primary Outcome
The length of time in days from the initiation of pharmacotherapy on day 1 until the medication has been stopped
Interventions
- DRUG Placebo
- DRUG Clonidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 4 |
Why NCT03762317 stopped before completion
NCT03762317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03762317 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03762317 about?
NCT03762317 is a clinical study titled "Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome". This is a prospective randomized double blinded study comparing the effect on duration of pharmacologic treatment and duration of hospital stay when using clonidine at 12 µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the management of term and near term infant...
What is the current status of trial NCT03762317?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2018-04-30. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT03762317?
The interventions under investigation include: Placebo (DRUG), Clonidine (DRUG).
Who is sponsoring clinical trial NCT03762317?
This trial is sponsored by Hennepin County Medical Center, Minneapolis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03762317's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI